Navigation Links
Caris Life Sciences erhält erste Akkreditierung als medizinisches Laboratorium nach ISO 15189 im Bereich Tumor-Profiling
Date:12/20/2013

IRVING, Texas, 20. Dezember 2013 /PRNewswire/ -- Wie Caris Life Sciences®, ein führendes Biotechnologieunternehmen und Innovator bei der personalisierten Medizin, bekanntgab, hat sein Tumor-Profiling-Labor in Phoenix im US-Bundesstaat Arizona von der American Association for Laboratory Accreditation (A2LA) die weltweit erste Akkreditierung als medizinisches Laboratorium nach ISO 15189 „Medizinische Laboratorien - Besondere Anforderungen an die Qualität und Kompetenz" im Bereich molekulares Profiling erhalten.  In dem Labor von Caris finden die Genomtests in Zusammenhang mit Caris Molecular Intelligence™ statt. Dieser branchenführende und umfassende Tumor-Profiling-Service hat bisher Profile für mehr als 50.000 Krebspatienten auf der ganzen Welt erstellt.  Neben der Akkreditierung nach ISO 15189 hat Caris die CLIA-Akkreditierung (Clinical Laboratory Improvement Amendments) sowie eine lange Liste von Zertifizierungen vom US-Bundesstaat New York erhalten. Das Unternehmen betreibt außerdem eines der wenigen kommerziellen Biorepositorys, das vom College of American Pathologists (CAP) akkreditiert ist.

„Es füllt uns mit Stolz, dass wir die Anerkennung und Bestätigung von externer Stelle für etwas bekommen haben, was Caris schon lange weiß – die Qualität unseres Labors ist industrieweit unangefochten", sagte David Spetzler, Ph.D., Vice President, Research and Development bei Caris Life Sciences.

ISO 15189 gilt in der Branche als die strengste regulatorische Norm, die man als Labor erfüllen kann. Die Akkreditierung ist Beweis für den Weltrang des Unternehmens. Mit dieser internationalen Norm werden die überragende Qualität, Servicekompetenz und Konsistenz bei der Lieferung gültiger Testergebnisse bei Caris anerkannt. Im Speziellen gilt d
'/>"/>

SOURCE Caris Life Sciences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Caris Life Sciences Receives Patent for Molecular Profiling Service in The Peoples Republic of China
2. Caris Life Sciences Presents Key Biomarker Data at 2013 Association for Molecular Pathology (AMP) Annual Meeting
3. Caris Life Sciences ASCO Presentation Highlights the Utility of Molecular Profiling for the Management of Rare and Aggressive Cancers
4. Caris Life Sciences Announces Planned Expansion of Next-Generation Sequencing (NGS) Capabilities
5. Caris Life Sciences Symposium to Explore Advances in Next Generation Sequencing for Gynecologic Cancers
6. Caris Life Sciences nimmt Next-Generation Sequencing zur Verbesserung des evidenzbasierten Tumorprofilierungsservices für Krebspatienten auf
7. Caris Life Sciences Adds Next-Generation Sequencing to Enhance Evidence-Based Tumor Profiling Service for Cancer Patients
8. Caris Sponsors CancerCare Connect Education Workshop on Molecular Profiling in the Treatment of Breast Cancer
9. Caris Life Sciences mejora la evaluación por perfil molecular con los biomarcadores ROS1 y MGMT-metilación
10. Caris Life Sciences Enhances Molecular Profiling Service with Addition of ROS1 and MGMT-Methylation Biomarkers
11. Proove Biosciences Successfully Presents Data and Exhibits at the Eastern Pain Association’s Annual Meeting in New York, New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... San Francisco, CA (PRWEB) April 16, 2015 ... is scheduled to report first quarter results on Thursday, ... the announcement, Cytokinetics’ senior management will host a conference ... and financial results and the company’s outlook for the ... and can be accessed from the homepage and in ...
(Date:4/16/2015)... 16, 2015 According to the ... an outside source was ranked first among the ... related to lifting, pushing, pulling, holding, carrying, or ... costs. The David Round Company takes statistics like ... working hard to develop and design equipment that ...
(Date:4/16/2015)... 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... joint venture with G-treeBNT (ReGenTree LLC) has retained ... trial for the orphan disorder, neurotrophic keratopathy (NK), ... eye syndrome (DES) in the U.S.  Both trials ... this year.  Each of these eye disorders was ...
(Date:4/16/2015)... Calif. , April 16, 2015  Scientists from ... "New Drugs on the Horizon," at the American Association ... Philadelphia, PA on Sunday, April 19, 2015 ... Ph.D., Cleave,s Director of Biology, will present new in ... a first-in-class, oral inhibitor of p97, a critical enzyme ...
Breaking Biology Technology:Cytokinetics to Announce First Quarter Results on April 30, 2015 2Cytokinetics to Announce First Quarter Results on April 30, 2015 3The David Round Company Helps Companies Meet OSHA Standards by Combining Safety, Ergonomics, and Productivity 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 2Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 3
... 30 Champions,Biotechnology, Inc. (OTC Bulletin Board: CSBR), ... platforms and tumor specific data to,enhance the value ... the fiscal year ended April 30, 2008. Full ... the Company,s Form 10-KSB available at, http://www.championsbiotechnology.com ., ...
... today announced that it has partnered with Green Mountain Energy Company ... total calculated carbon dioxide (CO2) emissions thereby enabling them to operate ... ... Mesa, CA (PRWEB) July 30, 2008 -- Alkemists Pharmaceuticals today announced ...
... announces the following Webcast:, What: Transgenomic Inc. ... Conference Call, When: Wednesday, August ... , How: Live over the Internet -- ... address above., Contact: Investor Relations, ...
Cached Biology Technology:Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results 2Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results 3Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results 4Alkemists Sets The Bar, Becoming a 'Green' Analytical Laboratory 2Alkemists Sets The Bar, Becoming a 'Green' Analytical Laboratory 3
(Date:4/2/2015)... , April 2, 2015 ... Q1 2015 attributed to somewhat higher than 125 MSEK. ... the year-end report 2014 that revenues for Q1 2015 ... the company reported for Q4 2014. The operating result ... be negative. The complete interim report will as previously ...
(Date:3/31/2015)... , March 31, 2015   Guidepoint , ... launch of the Post-Surgical Pain Management TRACKER, part of ... tracking usage trends in the medical device and therapeutics ... to data including treatment volumes, market share, and adoption ... pain associated with joint surgery. The Post-Surgical ...
(Date:3/24/2015)... NexID Biometrics LLC, whose spoof-mitigation technology boosts protection ... beginning of shipments of version 2.0 of its industry ... in Potsdam, N.Y. , is making ... here today at the Walter E. Washington Convention Center. ... boosts the accuracy rate range to 96.5 to 99.5 ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2
... Organization (EMBO) and the Federation of European Biochemical ... Friedrich Miescher Institute for Biomedical Research in Basel, ... Women in Science Award. Professor Gasser has been ... stability and epigenetics and her commitment to mentoring ...
... (New York, NY) The Alfred P. Sloan ... outstanding U.S. and Canadian researchers as recipients of Sloan ... fellowships are given to early-career scientists and scholars whose ... next generation of scientific leaders. "Today,s Sloan Research ...
... DETROIT Technology to restore vision through the use ... a Wayne State University professor and scientific director of ... Eye Institute has attracted additional funding for therapy ... grant from their affiliate, National Neurovision Research Institute, to ...
Cached Biology News:Susan M. Gasser to receive the 2012 FEBS/EMBO Women in Science Award 2Sloan Research Fellowships awarded to 126 young scholars 2Wayne State-licensed technology receives grant from the Foundation Fighting Blindness 2